Segall Bryant & Hamill’s SGHC SGHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.46M Sell
216,873
-15,346
-7% -$210K 0.03% 416
2026
Q2
$3.15M Sell
232,219
-14,281
-6% -$181K 0.04% 377
2026
Q1
$2.66M Buy
+246,500
New +$2.52M 0.04% 388
2025
Q2
– Sell
-327,626
Closed -$2.11M – 628
2025
Q1
$2.11M Buy
+327,626
New +$2.35M 0.03% 424
2024
Q3
– Sell
-935,570
Closed -$3.02M – 597
2024
Q2
$3.02M Buy
+935,570
New +$3.16M 0.05% 345

Other funds holding SGHC

Segall Bryant & Hamill's SGHC Position: Q3 2026 in Review

Segall Bryant & Hamill reduced its SGHC (SGHC) stake by 6.6% in Q3 2026, selling an estimated $210K and leaving 216,873 shares worth $2.46M. The position accounts for 0.03% of the portfolio, ranked #416.

Segall Bryant & Hamill first reported a position in SGHC in Q2 2024 and has held it in 5 quarters since. The position peaked at $3.15M in Q2 2026. 201 funds tracked by Wall St. Rank hold SGHC as of Q3 2026.

  • Segall Bryant & Hamill held 216,873 shares of SGHC worth $2.46M as of Q3 2026.
  • Segall Bryant & Hamill sold 15,346 SGHC shares in Q3 2026, an estimated $210K.
  • SGHC made up 0.03% of Segall Bryant & Hamill's portfolio in Q3 2026, its #416 holding.
  • Segall Bryant & Hamill first reported a position in SGHC in Q2 2024 and has held it in 5 quarters since.
  • Segall Bryant & Hamill's SGHC position peaked at $3.15M in Q2 2026.
  • 201 funds tracked by Wall St. Rank held SGHC as of Q3 2026.

Based on Segall Bryant & Hamill's 13F filing for Q3 2026, filed 16 Nov 2026.